-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Bionano Genomics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2017 to Q3 2024.
- Bionano Genomics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $24K, a 38.5% decline year-over-year.
- Bionano Genomics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$4K, a 100% decline year-over-year.
- Bionano Genomics, Inc. annual Income Tax Expense (Benefit) for 2023 was $62K, a 96.7% decline from 2022.
- Bionano Genomics, Inc. annual Income Tax Expense (Benefit) for 2022 was $1.88M.
- Bionano Genomics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$5.72M, a 19814% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)